Business Context and Reporting Period
This Form 8-K was filed by Intercontinental Exchange, Inc. (ICE) on October 28, 2022. The report addresses a material event concerning Bakkt Holdings, Inc., an equity method investee in which ICE held an approximate 68% economic interest following a merger in October 2021.
Key Financial Metrics and Material Changes
The filing details a significant impairment event at Bakkt for the three months ended September 30, 2022, which directly impacts ICE's investment valuation:
- Bakkt Impairment Loss: Bakkt recorded an estimated goodwill impairment of $1.3 billion to $1.4 billion and an impairment of indefinite-lived intangible assets of $150 million to $160 million.
- ICE Investment Carrying Value: As a result of the impairment, ICE expects to reduce the carrying value of its investment in Bakkt to approximately $400 million as of September 30, 2022, down from $1.5 billion as of June 30, 2022.
- Impact on Adjusted Earnings: The filing states this non-cash charge will have no impact on ICE's adjusted earnings for the three- and nine-month periods ended September 30, 2022.
The filing text does not provide specific revenue, profit, cash flow, or debt figures for Intercontinental Exchange, Inc. itself, as the quarterly results are scheduled for a separate announcement.
Guidance, Outlook, and Management Commentary
Management indicated that ICE plans to announce its quarterly results for the period ended September 30, 2022, on Thursday, November 3, 2022. The filing clarifies that the information provided is furnished pursuant to Item 2.02 and is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Verify the final impairment amounts for Bakkt in the company's official 8-K or press release.
- Review the upcoming quarterly earnings release on November 3, 2022, for the full impact on ICE's GAAP net income versus adjusted earnings.
- Confirm the updated carrying value of the Bakkt investment on ICE's balance sheet in the subsequent 10-Q filing.
- Assess any potential future goodwill impairment risks related to ICE's other equity method investments.